Cemile Baykan Eryiğit
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Cemile Baykan Eryiğit has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Adalet Aşkin
Department of Otorhinolaryngology, Başakşehir Çam and Sakura City Hospital, Istanbul 34480, Turkey
1 shared publication - Emre Baran
Department of Otorhinolaryngology, Istanbul Training and Research Hospital, Istanbul 34098, Turkey
1 shared publication - Feride Fırat
Department of Otorhinolaryngology, Başakşehir Çam and Sakura City Hospital, Istanbul 34480, Turkey
1 shared publication - Gülçin Hilal Alay
Intensive Care Unit, Başakşehir Çam and Sakura City Hospital, Istanbul 34480, Turkey
1 shared publication - Ozan Ozdemir
Department of Otorhinolaryngology Head and Neck Surgery, University of Health Sciences Istanbul Training And Research Hospital
1 shared publication - Ozgür Yiğit
Department of Otorhinolaryngology, Başakşehir Çam and Sakura City Hospital, Istanbul 34480, Turkey
1 shared publication
Latest Publications
- Open Access
- 16 November 2026
- Published by MDPI AG in Journal of Fungi
- Vol. 12 (11) , 859
Evaluation of Pre-Diagnostic Inflammatory and Nutritional Indices in Rhino-Cerebral Mucormycosis: A Matched Case–Control Study
Background and Objective: Rhino-cerebral mucormycosis (RCM) is an invasive fungal infection characterized by rapid progression and high mortality. We evaluated the association of routine inflammatory and nutritional indices, obtained before the otorhinolaryngology consultation prompted by sinonasal symptoms, with RCM in immunosuppressed patients. Materials and Methods: This retrospective, two-center, matched case–control study included 35 patients with RCM, defined by histopathologically identified hyphae consistent with Mucorales in debrided tissue (invasion or tissue damage documented in 12), and 79 immunosuppressed controls (2013–2026). Laboratory values were obtained a median of 10 days before this consultation. The neutrophil–lymphocyte ratio (NLR), systemic immune–inflammation index (SII), prognostic nutritional index (PNI), and C-reactive protein/albumin ratio (CAR) were evaluated using ROC analysis and conditional and penalized logistic regression. Results: NLR and SII did not differ between groups. The AUC was 0.846 (95% CI: 0.759–0.905) for CAR and 0.832 (95% CI: 0.731–0.900) for PNI; CRP alone performed similarly (AUC 0.833), and CAR added no information beyond CRP. In conditional analysis adjusted for neutropenia, both log2(CAR) (OR 1.85 per doubling; 95% CI: 1.15–2.99) and PNI (OR 0.88 per unit; 95% CI: 0.80–0.98) remained associated with RCM; in penalized models, the association of PNI was of borderline significance (p = 0.052–0.069). Conclusions: Elevated CAR measured before this consultation, largely reflecting CRP, was consistently associated with RCM; the association of low PNI was suggestive but model-dependent. These exploratory findings cannot be used to rule out RCM and require prospective validation.
- 16 November 2026
- Published by MDPI AG in Journal of Fungi
- Vol. 12 (11) , 859
Open AccessEvaluation of Pre-Diagnostic Inflammatory and Nutritional Indices in Rhino-Cerebral Mucormycosis: A Matched Case–Control Study
Background and Objective: Rhino-cerebral mucormycosis (RCM) is an invasive fungal infection characterized by rapid progression and high mortality. We evaluated the association of routine inflammatory and nutritional indices, obtained before the otorhinolaryngology consultation prompted by sinonasal symptoms, with RCM in immunosuppressed patients. Materials and Methods: This retrospective, two-center, matched case–control study included 35 patients with RCM, defined by histopathologically identified hyphae consistent with Mucorales in debrided tissue (invasion or tissue damage documented in 12), and 79 immunosuppressed controls (2013–2026). Laboratory values were obtained a median of 10 days before this consultation. The neutrophil–lymphocyte ratio (NLR), systemic immune–inflammation index (SII), prognostic nutritional index (PNI), and C-reactive protein/albumin ratio (CAR) were evaluated using ROC analysis and conditional and penalized logistic regression. Results: NLR and SII did not differ between groups. The AUC was 0.846 (95% CI: 0.759–0.905) for CAR and 0.832 (95% CI: 0.731–0.900) for PNI; CRP alone performed similarly (AUC 0.833), and CAR added no information beyond CRP. In conditional analysis adjusted for neutropenia, both log2(CAR) (OR 1.85 per doubling; 95% CI: 1.15–2.99) and PNI (OR 0.88 per unit; 95% CI: 0.80–0.98) remained associated with RCM; in penalized models, the association of PNI was of borderline significance (p = 0.052–0.069). Conclusions: Elevated CAR measured before this consultation, largely reflecting CRP, was consistently associated with RCM; the association of low PNI was suggestive but model-dependent. These exploratory findings cannot be used to rule out RCM and require prospective validation.